NewAmsterdam Pharma Company N.V.

NAMS

NAMSNewAmsterdam Pharma Company N.V. US flag

NASDAQ Capital Market

32.11

USD

+0.40

- -

3.75BMarket Cap

Profitability (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-105.73	-8.29	-42.86	-39.88	-24.95
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100
EBITDA Margin (%)	- -	- -	-3.45	-1,298.21	-386.66	-1,001.92
Operating Margin (%)	- -	- -	-3.46	-1,298.56	-386.91	-1,002.9
Incremental Operating Margin (%)	- -	- -	35.63	- -	- -	- -
Pretax Margin (%)	- -	- -	-22.04	-1,255.57	-530.25	-905.74
Profit Margin (%)	- -	- -	-22.04	-1,255.76	-530.25	-905.74
Net Income to Common Margin (%)	- -	- -	-22.04	-1,255.76	-530.25	-905.74
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	14	- -	- -	- -	- -	- -
ST Debt	14	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-2.21	-0.01	-0.04	- -	- -	- -
Net Debt/EBITDA	-0.72	1.74	131.83	1.86	4.38	2.17
Total Debt/EBIT	-2.21	-0.01	-0.04	- -	- -	- -
Net Debt/EBIT	-0.72	1.73	131.5	1.86	4.38	2.17
EBITDA to Interest Expense	-15.34	-84.3	-12.36	- -	- -	- -
EBITDA-CapEx/Interest Expense	-15.38	-84.36	-13.13	- -	- -	- -
EBIT to Interest Expense	-15.34	-84.31	-12.39	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-38.75	82.3	-27.16	-88.39	-63.05	-97.25
Long-Term Debt/Equity (%)	- -	0.22	0.01	- -	0.03	0.01
Long-Term Debt/Capital (%)	- -	0.22	-0.05	- -	-0.04	-0.01
Long-Term Debt/Total Assets (%)	- -	0.19	0.01	- -	0.02	0.01
Total Debt/Equity (%)	-325.69	0.33	0.03	0.02	0.06	0.03
Total Debt/Capital (%)	144.31	0.33	-0.1	-0.02	-0.08	-0.03
Total Debt/Total Assets (%)	126.21	0.27	0.03	0.02	0.05	0.03
Net Debt to Equity	-105.93	-106.63	-108.76	-118.05	-101.88	-71.7
Net Debt/Capital (%)	1,787.26	1,424.14	78.27	52.6	58.62	39.58
EBITDA	-6	-35	-4	-183	-176	-225
EBITDA-CapEx	-7	-35	-4	-183	-177	-226
Operating Income (Loss)	-6	-35	-4	-183	-176	-226

Liquidity (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.61	5.37	12.97	6.82	7.8	7.42
Current Ratio	0.72	5.96	13.26	6.95	8.08	7.88
Quick Ratio	0.72	5.81	13.03	6.86	8	7.69
CFO/Avg Current Liab	- -	-2.19	0.45	-3.29	-2.02	-1.53
Common Equity/Total Assets	-38.75	82.3	-27.16	-88.39	-63.05	-97.25
Long-Term Debt/Equity (%)	- -	0.22	0.01	- -	0.03	0.01
Long-Term Debt/Capital (%)	- -	0.22	-0.05	- -	-0.04	-0.01
Long-Term Debt/Total Assets (%)	- -	0.19	0.01	- -	0.02	0.01
Total Debt/Equity (%)	-325.69	0.33	0.03	0.02	0.06	0.03
Total Debt/Capital (%)	144.31	0.33	-0.1	-0.02	-0.08	-0.03
Total Debt/Total Assets (%)	126.21	0.27	0.03	0.02	0.05	0.03
CFO/Total Liabilities	-46.61	-260.89	22.02	-240.56	-148.02	-172.13
CFO/CapEx	-459.23	-1,229.67	48.26	-5,884.08	-235.96	-600.74
Altman's Z-Score	-3.28	35.53	3.28	6.55	12.64	23.31

Working Capital (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	699	193	831	2,342	3,537
- Cash & Cash Equivalents	10	60	468	340	772	490
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	14	- -	- -	- -	- -	- -
Enterprise Value	5	639	-274	491	1,508	2,901
Total Capital	10	56	-130	-307	-545	-748
Total Debt/Capital (%)	144.31	0.33	-0.1	-0.02	-0.08	-0.03
Total Debt / EV	3.07	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	34.85	33.1	128.91
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	699	193	831	2,342	3,537
Diluted Enterprise Value	5	639	-274	491	1,571	3,047
EV per Share	0.06	7.83	- -	5.98	15.98	24.49
TTM Sales	- -	- -	103	14	46	23
TTM EBITDA	-6	-35	-4	-183	-176	-225
TTM Operating Income	-6	-35	-4	-183	-176	-226
TTM Cash Flow to Firm	-7	-29	11	-141	-159	-148
TTM Free Cash Flow to Firm	-7	-29	11	-141	-158	-148

Multiples (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	-23.69	17.75	-5.89	-14.83	-23.97
EV/EBIT	- -	- -	- -	- -	- -	- -
Enterprise Value	5	639	-274	491	1,508	2,901
Low Price	- -	7.93	7.28	5.33	10.22	12.87
EV/Sales	- -	- -	- -	34.85	33.1	128.91
EV/EBITDA	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-16.33	-7.89	-4.92	-7.13	-12.96
Price/Earnings High	- -	-19.98	-26.5	-7.99	-10.17	-21.04
Price/Earnings Low	- -	-15.47	-6.1	-2.48	-3.99	-7.48
Price/Book Value	- -	12.54	-1.49	-2.71	-4.3	-4.73
Price/Book Value Average	- -	12.25	-1.37	-2.83	-3.16	-3.53
Price/Book Value High	- -	14.99	-4.62	-4.61	-4.51	-5.73
Price/Book Value Low	- -	11.61	-1.06	-1.43	-1.77	-2.04
Price/Tangible Book Value	- -	12.39	0.45	2.88	3.09	5.18
Price/Tangible Book Value Average	- -	12.11	0.42	3.02	2.28	3.87
Price/Tangible Book Value High	- -	14.81	1.4	4.91	3.25	6.28
Price/Tangible Book Value Low	- -	11.47	0.32	1.52	1.27	2.23
Price/Sales	- -	- -	1.88	59.01	51.4	157.17
Price/Sales Average	- -	- -	1.74	61.72	37.81	117.43
Price/Sales High	- -	- -	5.84	100.36	53.92	190.6
Price/Sales Low	- -	- -	1.34	31.1	21.17	67.72
Price/Cash Flow	- -	-23.67	18.12	-5.89	-14.77	-23.93
Price/Cash Flow Average	- -	-23.13	16.74	-6.16	-10.87	-17.88
Price/Cash Flow High	- -	-28.28	56.25	-10.01	-15.49	-29.02
Price/Cash Flow Low	- -	-21.91	12.95	-3.1	-6.08	-10.31
Price/Free Cash Flow Average	- -	-23.14	16.4	-6.16	-10.91	-17.91
Price/Free Cash Flow High	- -	-28.31	55.11	-10.01	-15.56	-29.07
Price/Free Cash Flow Low	- -	-21.93	12.68	-3.1	-6.11	-10.33
EV/Sales Average	- -	- -	- -	37.57	20.88	95.66
EV/Sales High	- -	- -	1.29	76.2	36.99	168.84
EV/Sales Low	- -	- -	- -	6.94	4.24	45.95
EV/EBITDA Average	-0.72	-17.97	81.49	-2.89	-5.4	-9.55
EV/EBITDA High	-0.72	-22.36	-37.29	-5.87	-9.57	-16.85
EV/EBITDA Low	-0.72	-16.93	92.87	-0.53	-1.1	-4.59
EV/EBIT Average	-0.72	-17.97	81.28	-2.89	-5.4	-9.54
EV/EBIT High	-0.72	-22.36	-37.2	-5.87	-9.56	-16.83
EV/EBIT Low	-0.72	-16.93	92.64	-0.53	-1.1	-4.58
Last Price	- -	8.57	10.19	10.12	24.82	29.87
High Price	- -	10.23	31.63	17.21	26.03	36.22
Enterprise Value Average	5	623	-289	529	952	2,153
Enterprise Value High	5	775	132	1,074	1,685	3,799
Enterprise Value Low	5	587	-330	98	193	1,034

Profitability (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-105.73	-8.29	-42.86	-39.88	-24.95
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100
EBITDA Margin (%)	- -	- -	-3.45	-1,298.21	-386.66	-1,001.92
Operating Margin (%)	- -	- -	-3.46	-1,298.56	-386.91	-1,002.9
Incremental Operating Margin (%)	- -	- -	35.63	- -	- -	- -
Pretax Margin (%)	- -	- -	-22.04	-1,255.57	-530.25	-905.74
Profit Margin (%)	- -	- -	-22.04	-1,255.76	-530.25	-905.74
Net Income to Common Margin (%)	- -	- -	-22.04	-1,255.76	-530.25	-905.74
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	14	- -	- -	- -	- -	- -
ST Debt	14	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-2.21	-0.01	-0.04	- -	- -	- -
Net Debt/EBITDA	-0.72	1.74	131.83	1.86	4.38	2.17
Total Debt/EBIT	-2.21	-0.01	-0.04	- -	- -	- -
Net Debt/EBIT	-0.72	1.73	131.5	1.86	4.38	2.17
EBITDA to Interest Expense	-15.34	-84.3	-12.36	- -	- -	- -
EBITDA-CapEx/Interest Expense	-15.38	-84.36	-13.13	- -	- -	- -
EBIT to Interest Expense	-15.34	-84.31	-12.39	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-38.75	82.3	-27.16	-88.39	-63.05	-97.25
Long-Term Debt/Equity (%)	- -	0.22	0.01	- -	0.03	0.01
Long-Term Debt/Capital (%)	- -	0.22	-0.05	- -	-0.04	-0.01
Long-Term Debt/Total Assets (%)	- -	0.19	0.01	- -	0.02	0.01
Total Debt/Equity (%)	-325.69	0.33	0.03	0.02	0.06	0.03
Total Debt/Capital (%)	144.31	0.33	-0.1	-0.02	-0.08	-0.03
Total Debt/Total Assets (%)	126.21	0.27	0.03	0.02	0.05	0.03
Net Debt to Equity	-105.93	-106.63	-108.76	-118.05	-101.88	-71.7
Net Debt/Capital (%)	1,787.26	1,424.14	78.27	52.6	58.62	39.58
EBITDA	-6	-35	-4	-183	-176	-225
EBITDA-CapEx	-7	-35	-4	-183	-177	-226
Operating Income (Loss)	-6	-35	-4	-183	-176	-226

Liquidity (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.61	5.37	12.97	6.82	7.8	7.42
Current Ratio	0.72	5.96	13.26	6.95	8.08	7.88
Quick Ratio	0.72	5.81	13.03	6.86	8	7.69
CFO/Avg Current Liab	- -	-2.19	0.45	-3.29	-2.02	-1.53
Common Equity/Total Assets	-38.75	82.3	-27.16	-88.39	-63.05	-97.25
Long-Term Debt/Equity (%)	- -	0.22	0.01	- -	0.03	0.01
Long-Term Debt/Capital (%)	- -	0.22	-0.05	- -	-0.04	-0.01
Long-Term Debt/Total Assets (%)	- -	0.19	0.01	- -	0.02	0.01
Total Debt/Equity (%)	-325.69	0.33	0.03	0.02	0.06	0.03
Total Debt/Capital (%)	144.31	0.33	-0.1	-0.02	-0.08	-0.03
Total Debt/Total Assets (%)	126.21	0.27	0.03	0.02	0.05	0.03
CFO/Total Liabilities	-46.61	-260.89	22.02	-240.56	-148.02	-172.13
CFO/CapEx	-459.23	-1,229.67	48.26	-5,884.08	-235.96	-600.74
Altman's Z-Score	-3.28	35.53	3.28	6.55	12.64	23.31

Working Capital (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	699	193	831	2,342	3,537
- Cash & Cash Equivalents	10	60	468	340	772	490
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	14	- -	- -	- -	- -	- -
Enterprise Value	5	639	-274	491	1,508	2,901
Total Capital	10	56	-130	-307	-545	-748
Total Debt/Capital (%)	144.31	0.33	-0.1	-0.02	-0.08	-0.03
Total Debt / EV	3.07	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	34.85	33.1	128.91
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	699	193	831	2,342	3,537
Diluted Enterprise Value	5	639	-274	491	1,571	3,047
EV per Share	0.06	7.83	- -	5.98	15.98	24.49
TTM Sales	- -	- -	103	14	46	23
TTM EBITDA	-6	-35	-4	-183	-176	-225
TTM Operating Income	-6	-35	-4	-183	-176	-226
TTM Cash Flow to Firm	-7	-29	11	-141	-159	-148
TTM Free Cash Flow to Firm	-7	-29	11	-141	-158	-148

Multiples (EUR)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	-23.69	17.75	-5.89	-14.83	-23.97
EV/EBIT	- -	- -	- -	- -	- -	- -
Enterprise Value	5	639	-274	491	1,508	2,901
Low Price	- -	7.93	7.28	5.33	10.22	12.87
EV/Sales	- -	- -	- -	34.85	33.1	128.91
EV/EBITDA	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-16.33	-7.89	-4.92	-7.13	-12.96
Price/Earnings High	- -	-19.98	-26.5	-7.99	-10.17	-21.04
Price/Earnings Low	- -	-15.47	-6.1	-2.48	-3.99	-7.48
Price/Book Value	- -	12.54	-1.49	-2.71	-4.3	-4.73
Price/Book Value Average	- -	12.25	-1.37	-2.83	-3.16	-3.53
Price/Book Value High	- -	14.99	-4.62	-4.61	-4.51	-5.73
Price/Book Value Low	- -	11.61	-1.06	-1.43	-1.77	-2.04
Price/Tangible Book Value	- -	12.39	0.45	2.88	3.09	5.18
Price/Tangible Book Value Average	- -	12.11	0.42	3.02	2.28	3.87
Price/Tangible Book Value High	- -	14.81	1.4	4.91	3.25	6.28
Price/Tangible Book Value Low	- -	11.47	0.32	1.52	1.27	2.23
Price/Sales	- -	- -	1.88	59.01	51.4	157.17
Price/Sales Average	- -	- -	1.74	61.72	37.81	117.43
Price/Sales High	- -	- -	5.84	100.36	53.92	190.6
Price/Sales Low	- -	- -	1.34	31.1	21.17	67.72
Price/Cash Flow	- -	-23.67	18.12	-5.89	-14.77	-23.93
Price/Cash Flow Average	- -	-23.13	16.74	-6.16	-10.87	-17.88
Price/Cash Flow High	- -	-28.28	56.25	-10.01	-15.49	-29.02
Price/Cash Flow Low	- -	-21.91	12.95	-3.1	-6.08	-10.31
Price/Free Cash Flow Average	- -	-23.14	16.4	-6.16	-10.91	-17.91
Price/Free Cash Flow High	- -	-28.31	55.11	-10.01	-15.56	-29.07
Price/Free Cash Flow Low	- -	-21.93	12.68	-3.1	-6.11	-10.33
EV/Sales Average	- -	- -	- -	37.57	20.88	95.66
EV/Sales High	- -	- -	1.29	76.2	36.99	168.84
EV/Sales Low	- -	- -	- -	6.94	4.24	45.95
EV/EBITDA Average	-0.72	-17.97	81.49	-2.89	-5.4	-9.55
EV/EBITDA High	-0.72	-22.36	-37.29	-5.87	-9.57	-16.85
EV/EBITDA Low	-0.72	-16.93	92.87	-0.53	-1.1	-4.59
EV/EBIT Average	-0.72	-17.97	81.28	-2.89	-5.4	-9.54
EV/EBIT High	-0.72	-22.36	-37.2	-5.87	-9.56	-16.83
EV/EBIT Low	-0.72	-16.93	92.64	-0.53	-1.1	-4.58
Last Price	- -	8.57	10.19	10.12	24.82	29.87
High Price	- -	10.23	31.63	17.21	26.03	36.22
Enterprise Value Average	5	623	-289	529	952	2,153
Enterprise Value High	5	775	132	1,074	1,685	3,799
Enterprise Value Low	5	587	-330	98	193	1,034

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	82	82	82	82	108	114
Diluted Weighted Avg Shares	82	82	19	82	94	118
Basic Weighted Avg Shares	82	82	19	82	94	118
Revenue per Share	- -	- -	5.41	0.17	0.48	0.19
EBITDA per Share	-0.08	-0.42	-0.19	-2.23	-1.87	-1.9
Operating Income per Share	-0.08	-0.42	-0.19	-2.23	-1.87	-1.91
Basic EPS, GAAP	-0.09	-0.51	-1.19	-2.15	-2.56	-1.72
Basic EPS from Cont Ops	-0.09	-0.51	-1.19	-2.15	-2.56	-1.72
Diluted EPS, GAAP	-0.09	-0.51	-1.19	-2.15	-2.56	-1.72
Diluted EPS from Cont Ops	-0.09	-0.51	-1.19	-2.15	-2.56	-1.72
Dividend per Share	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.09	-0.36	0.56	-1.72	-1.68	-1.25
Free Cash Flow per Basic Share	-0.09	-0.36	0.55	-1.72	-1.69	-1.25
Cash & Equivalents per Share	0.12	0.74	24.66	4.14	8.84	5.37
Book Value per Share	-0.05	0.68	-6.85	-3.73	-5.78	-6.32
Tangible Book Value per Share	-0.05	0.69	22.66	3.51	8.02	5.77

NewAmsterdam Pharma Company N.V.

Profitability (EUR)

Credit (EUR)

Liquidity (EUR)

Working Capital (EUR)

Enterprise Value (EUR)

Multiples (EUR)

Profitability (EUR)

Credit (EUR)

Liquidity (EUR)

Working Capital (EUR)

Enterprise Value (EUR)

Multiples (EUR)

Per Share Data Items (EUR)